An Ascending, Multiple-Dose, Safety and Tolerability Study of Tecarfarin in Healthy Chinese Volunteers

PHASE1UnknownINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 19, 2020

Primary Completion Date

December 5, 2020

Study Completion Date

December 30, 2020

Conditions

Healthy Chinese Volunteers

Interventions

DRUG

Tecarfarin

Ten (10) healthy Chinese subjects received once-daily doses of Tecarfarin on fasting every morning for 14 days.

Trial Locations (1)

The Second Hospital of Anhui Medical University, Hefei